newsfilter
← Latest News
GlobeNewswire·

Albireo to Present at the William Blair Biotech Focus Conference 2022

BOSTON, June 30, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a rare liver disease company developing novel bile acid modulators, today announced participation at the William Blair Biotech Focus Conference July 12-13, 2022. Ron Cooper,